checkAd

     344  0 Kommentare Hansen Medical(R) Announces Exclusive Distribution Agreement for Switzerland With AB Medica Sagl - Seite 2

    • Provides predictability, control and catheter stability as a physician navigates a patient's peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices.
    • Is designed to enable more predictable procedure times and increased case throughput, potentially allowing hospitals to improve utilization within their vascular business line.
    • Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today.
    • Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation field and without wearing heavy lead as required in conventional endovascular procedures. 
    • The Magellan 9Fr and 10Fr Robotic Catheters allow for independent, robotic control of two telescoping catheters (an outer Guide and an inner Leader catheter), as well as robotic manipulation of standard guide wires.
    • The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires. This smaller catheter design may be preferred by certain physicians who prefer a smaller diameter vessel access site, or in procedures in smaller vessels. 

    About Hansen Medical, Inc.
    Hansen Medical, Inc., based in Mountain View, California, is the global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, Magellan Robotic Catheters, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Company's mission is to enable cardiac arrhythmia and endovascular procedures and to improve patient outcomes through the use of intravascular robotics. Additional information can be found at www.hansenmedical.com.

    Seite 2 von 4






    Verfasst von Marketwired
    Hansen Medical(R) Announces Exclusive Distribution Agreement for Switzerland With AB Medica Sagl - Seite 2 MOUNTAIN VIEW, CA--(Marketwired - Oct 1, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced that it has signed an exclusive agreement with AB Medica Sagl for distribution of the Magellan™ …

    Schreibe Deinen Kommentar

    Disclaimer